As pension, sovereign and private equity funds rush to invest in prime London real estate, Linklaters has picked up a major client as Australia’s largest pension fund purchased a 42% stake in the £5bn redevelopment of King’s Cross.
Match of the Day: Jones Day, Herbert Smith and Walker Morris score roles on Crystal Palace FC investment
Teams from Jones Day, Herbert Smith Freehills and Walker Morris have won mandates as Premier League football club Crystal Palace FC restructures in an ownership deal with US billionaires Josh Harris and David Blitzer which includes an initial £50m investment.
Checking in: Freshfields and Stephenson Harwood advise on £1.3bn sale of the Priory
Freshfields Bruckhaus Deringer and Stephenson Harwood have led on the sale of the Priory, the rehab clinic known for its celebrity clients, having treated the likes of supermodel Kate Moss, pop star Robbie Williams and rocker Pete Doherty.
Dealwatch: Freshfields acts for Deutsche Bank as it sells ¥25.7bn of Chinese assets
After winning a place on Deutsche Bank’s global legal panel last year, Freshfields Bruckhaus Deringer is representing the German bank on the sale of ¥25.7bn of its Chinese assets.
Freshfields and Latham act on creation of new PE house as Barclays spins-off another venture
Private equity heavyweights Freshfields Bruckhaus Deringer and Latham & Watkins have acted on the spin-off of Barclays’ natural resources private equity arm through a management buyout.
Dealwatch: US firms line up as Russia’s largest driller prepares exit from London stock exchange
The management of Eurasia Drilling Company Limited is being advised by US firm Willkie Farr & Gallagher as it prepares to sell to major shareholders and exit the London stock exchange, after Schlumberger gave up on a deal to buy into the company.
Dealwatch: Sullivan & Cromwell’s City office and CC advise on nearly £6bn worth of deals
Sullivan & Cromwell’s City office has been busy this summer winning roles on two headline deals announced yesterday [8 September], working alongside Clifford Chance (CC) on both Cinven’s £2.3bn sale of pharmaceuticals group Amdipharm Mercury Company (AMCo) and advising Goldman Sachs on Mitsui Sumitomo’s £3.5bn Amlin purchase.
Teva’s $40bn generic-drug buy sees Latham & Watkins and Sullivan & Cromwell lead
Cross-border teams from Sullivan & Cromwell and Latham & Watkins have landed the lead roles on the $40bn takeover of Allergan’s generic-making business by Teva that has seen the Israeli pharmaceutical powerhouse also abandon its bid for Mylan.
Continue reading “Teva’s $40bn generic-drug buy sees Latham & Watkins and Sullivan & Cromwell lead”
Dealwatch: Herbert Smith Freehills leads on winning bid for £4.2bn Thames super-sewer project
Herbert Smith Freehills (HSF) have advised the consortium picked to deliver a £4.2bn super-sewer stretching 15 miles under London to prevent untreated sewage flowing into the Thames.
Dealwatch: Linklaters and CC act on New Look sale as South African billionaire Wiese continues UK high street buy-up
Less than 30 days after advising on the £1.3bn purchase of Virgin Active by South African billionaire Christo Wiese’s private equity vehicle Brait, Linklaters‘ rising star Alex Woodward has led on Brait’s £780m deal for a 90% stake in clothing retailer New Look.